In addition, these DEGs modulate the MAPK cascade and ERK signaling, with ERK1/2 being of high interest in the pathogenesis of psoriasis because it serves as a target for glucocorticoids, which are used as a standard treatment (41, 42). This evidence concerns the gene MAPK3 and psoriasis.